Novo Nordisk

DC · 49 filings, 2025

File · Money Read

What the money shows

NOVO Nordisk reported $7.2M in federal lobbying for 2025 across 49 filings. The filings name 13 lobbying firms, led by Checkmate Government Relations and Nickles. The matched PAC file shows $55,000 to 0 lawmakers. The filing text lists 9 issue areas.

Sources: Senate LDA · FEC

Lobbying spend · 2025

$7.2M

to shape legislation

Its PAC gave

$55K

◆ Novo Nordisk PAC → 6 lawmakers

About the organization

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S (wholly owned by the Novo Nordisk Foundation) which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares. via Wikipedia ↗

1Lobbies on

Health Other Banking Tech Foreign

Its filings list: Health Issues · Medicare/Medicaid · Budget/Appropriations · Taxation/Internal Revenue Code · Copyright/Patent/Trademark · Pharmacy · Tariff (miscellaneous tariff bills) · Trade (domestic/foreign) · Consumer Issues/Safety/Products

2Through these firms · 13

CHECKMATE GOVERNMENT RELATIONSTHE NICKLES GROUP, LLCHOLLAND & KNIGHT LLPPUBLIC STRATEGIES WASHINGTON, INC.NOVO NORDISK INC.ARNOLD & PORTER KAYE SCHOLER LLPNVG, LLCTODD STRATEGY GROUPWILLIAMS AND JENSEN, PLLCTARPLIN, DOWNS & YOUNG, LLCAVOQ, LLCBALLARD PARTNERSTHE MADISON GROUP

3Shows up in these bills · 1

S 4189Caps insulin costs at $35 per month

4And its PAC funds these lawmakers · 6

Democrats · 4$35,000

Republicans · 2$20,000